D. E. Shaw & Co., Inc. Acadia Pharmaceuticals Inc Put Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $1.06 Million - $1.52 Million	-47,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $1.39 Million - $1.8 Million	47,000	47,000 $1.77 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.